MFSD2A and clear cell renal carcinoma: Circulating &lt;i&gt;ERVFRD-1&lt;/i&gt; and &lt;i&gt;MFSD2A&lt;/i&gt; Are Associated with Immunotherapy Response in Metastatic Clear Cell Renal Cell Carcinoma.